MLYS Mineralys Therapeutics Inc. Common Stock

USD 12.78 -0.06 -0.46729
Icon

Mineralys Therapeutics Inc. Common Stock (MLYS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 12.78

-0.06 (-0.47)%

USD 0.63B

0.08M

USD 33.00(+158.22%)

USD 22.00 (+72.14%)

Icon

MLYS

Mineralys Therapeutics Inc. Common Stock (USD)
COMMON STOCK | NSD
USD 12.78
0.00 0
Take a Tour

Mineralys Therapeutics Inc. Common Stock (MLYS) Stock Forecast

USD 33.00
(+158.22%)

Based on the Mineralys Therapeutics Inc. Common Stock stock forecast from 1 analysts, the average analyst target price for Mineralys Therapeutics Inc. Common Stock is USD 33.00 over the next 12 months. Mineralys Therapeutics Inc. Common Stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Mineralys Therapeutics Inc. Common Stock is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Mineralys Therapeutics Inc. Common Stock’s stock price was USD 12.78. Mineralys Therapeutics Inc. Common Stock’s stock price has changed by -4.56% over the past week, -20.08% over the past month and -19.97% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...